Birmingham, West Midlands -- (SBWIRE) -- 01/14/2014 -- Value Penny Stocks issues special report on Glu Mobile Inc. (NASDAQ:GLUU), Foster Wheeler AG (NASDAQ:FWLT), Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP).
Glu Mobile Inc. (NASDAQ:GLUU) opened its last trade at the price of $4.19. Its closing price was $4.00 after losing -4.08% for the day. The company traded with the total volume of 3,741,052 shares, while its average trading volume remained 2.68 million shares. The beta of this stock stands at 1.73. Glu Mobile Inc. develops and publishes a portfolio of action/adventure and casual games for the users of smartphones and tablet devices. The company develops games based on its own brands, including Blood & Glory, Big Time Gangsta, Contract Killer, Contract Killer: Zombies, Deer Hunter, Eternity Warriors, Frontline Commando, Gun Bros, Samurai vs. Zombies Defense, and Stardom, as well as third-party licensed brands.
Has GLUU Found The Bottom and Ready To Move Up? Find Out Here
Foster Wheeler AG (NASDAQ:FWLT) percentage change plunged -1.05% to close at $31.13 with the total traded volume of 8,302,033 shares, along with average volume of 1.15 million shares. The 52 week range of the stock remained $19.29 - $33.08, while its day lowest price was $30.87. The share price hit the day highest price of $32.10. Foster Wheeler AG, through its subsidiaries, operates in engineering and construction, as well as power generating equipment businesses worldwide. Its Global Engineering and Construction Group segment designs, engineers, and constructs onshore and offshore upstream oil and gas processing facilities.
Has FWLT Found The Bottom And Ready To Gain Momentum? Find Out Here
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) traded on volume of 2,939,007 shares in the last session against average volume of 434,629.00 shares. The company started its trading session with the price of $1.70 and closed at $1.81 by scoring +9.04%. Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic.
Will ONCY Continue To Move Higher? Find Out Here
Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP) started its last trading session with the price of $39.33 and closed at $39.14 by scoring 0.49%. The stock traded with total volume of 8,243,867 shares, while the average trading volume remained 3.89 million shares. The beta value of this stock stands at 1.30. Day range for the stock was $38.64 - $40.59. Ctrip.com International, Ltd., together with its subsidiaries, provides travel service for hotel accommodations, airline tickets, packaged tours, and corporate travel management in the People’s Republic of China. It also offers independent leisure travelers bundled packaged-tour products.
Why Should Investors Buy CTRP After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)